Return to homepagePandemic Pact

CEIRR: SARS-COV-2 Research Activities

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93021C00018-0-9999-3

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $100,000

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    S Mark Tompkins

  • Research Location

    United States of America

  • Lead Research Institution

    University Of Georgia

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

CEIRR will determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of respiratory viruses such as SARS-CoV-2, and characterize the immune response to infection to improve understanding of the immune correlates of protection and cross-protection. CEIRR will carry out a host of activities, including cohort studies and human and animal sampling to further understanding of respiratory infections, transmission and vaccination; identification of immunological factors that determine disease outcome in the response to infection and vaccination; and studies to determine how coronaviruses evolve, adapt and transmit between humans and at interspecies interfaces.